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Abstract
Background: The JNK pathway is a mitogen-activated protein (MAP) kinase pathway involved in the regulation of numerous
physiological processes during development and in response to environmental stress. JNK activity is controlled by two MAPK
kinases (MAPKK), Mkk4 and Mkk7. Mkk7 plays a prominent role upon Tumor Necrosis Factor (TNF) stimulation. Eiger, the
unique TNF-superfamily ligand in Drosophila, potently activates JNK signaling through the activation of the MAPKKK Tak1.
Methodology/Principal Findings: In a dominant suppressor screen for new components of the Eiger/JNK-pathway in
Drosophila, we have identified an allelic series of theMkk4 gene. Our genetic and biochemical results demonstrate that Mkk4 is
dispensable for normal development and host resistance to systemic bacterial infection but plays a non-redundant role as a
MAPKK acting in parallel to Hemipterous/Mkk7 in dTAK1-mediated JNK activation upon Eiger and Imd pathway activation.
Conclusions/Significance: In contrast to mammals, it seems that in Drosophila both MAPKKs, Hep/Mkk7 and Mkk4, are
required to induce JNK upon TNF or pro-inflammatory stimulation.
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Introduction
The JNK pathway, one of the three major classes of mitogen-
activated protein (MAP) kinase pathways (Erk, p38 and JNK), is
induced by pro-inflammatory cytokines, such as Tumor Necrosis
Factor (TNF) and Interleukin-1 (IL-1), and several forms of
environmental stress (e.g. osmotic stress, irradiation, and oxidative
stress) [1]. In mammals, JNK is reported to be activated by two
MAPK kinases (MAPKK) Mkk4 and Mkk7, with Mkk7 as the
major MAPKK in TNF- or IL-1-induced JNK activation while
both, Mkk4 and Mkk7, are required for stress induced activation
of JNK [2]. In mammals, Mkk7 is a specific activator of JNKs
while Mkk4 can also phosphorylate p38 MAPKs [3]. In mice,
analysis of the relative contribution of Mkk4 and Mkk7 to JNK
activation has been complicated by the fact that Mkk4 and Mkk7
single mutants are embryonic lethal [2].
Drosophila orthologs of Mkk4 and Mkk7 have been identified
[4,5,6]. So far, only mutations in hemipterous/Mkk7 (hep), have been
isolated [4]. Hep phosphorylates and activates the Drosophila JNK,
Basket (Bsk) [7] and null mutations in hep lead to a defect in dorsal
closure, a well characterized process in the Drosophila embryo that
entirely depends on JNK signaling [4,7]. In contrast to mammals,
Drosophila Mkk4 only activates JNK but not p38 in vitro [5,8],
however this remains controversial [6]. To date no mutants for
Drosophila Mkk4 have been identified and its functional relevance
towards JNK activation therefore remains elusive. Based on the
embryonic lethality of hepmutants it is obvious that Mkk4, which is
expressed during embryonic development, cannot substitute for
Hep function in this process. Although it has been reported that in
mammals Mkk4 and Mkk7 may synergistically activate JNK [9], it
does not seem to be the case for Hep-mediated Bsk activation
during dorsal closure.
In a dominant suppressor screen for new components of the
Eiger-JNK-pathway in Drosophila [10], we have identified an allelic
series of the Drosophila Mkk4 gene. Our genetic and biochemical
experiments now demonstrate a non-redundant role for Mkk4 as a
MAPKK acting in parallel of Hep in dTAK1-mediated JNK
activation during both Eiger and Imd signaling.
Results and Discussion
Mutations in Mkk4 Suppress Eiger Mediated Small Eye
Phenotype
In a dominant suppressor screen for new components of the
Eiger-JNK-pathway in Drosophila [10], we identified 21 EMS
mutations suppressing Eiger-induced cell death in the eye that
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mapped genetically very close to a deficiency (Df(3R)Exel6149) that
also suppresses the Eiger-induced small eye phenotype (Figure 1D).
This deficiency removes 26 genes including Mkk4. We sequenced
the coding region of Mkk4 in those EMS alleles and molecular
lesions were detected in all of them. Several mutations create a
premature stop codon in the open reading frame and therefore
Figure 1. Mkk4 triggers Eiger-mediated small eye phenotype. (A) Schematic representation of Mkk4. Alleles (black) and Ser/Thr
phosphorylation sites (green) are indicated. (B)–(J) are in a GMR-egr (GMR-Gal4,UAS-egr) background. (B) GMR-Gal4/+ control eye. (C) GMR-egr/+ small
eye. (D) GMR-egr/+; Df(3L)Exel6149/+. (E) GMR-egr/+; Mkk4G680/+. Removing one copy of Mkk4 suppresses the small eye phenotype. (F) GMR-egr/+;
Mkk4G680/Df(3L)Exel6149. Removing both copies of Mkk4 does not improve the suppression. (G) hep1; GMR-egr/+. Males hemizygous mutant for a
hypomorphic hep allele display a strong suppression of the small eye. (H) GMR-egr/tub-Mkk4; Mkk4G680/+. A Mkk4 rescue transgene reverts the
dominant suppression observed by loss of one copy of Mkk4. (I) GMR-egr/UAS-Mkk4. Co-expression of Mkk4 has dominant negative effect on Eiger
signal transduction. (J) GMR-egr/UAS-Mkk4Asp. The same effect is observed for Mkk4Asp. (K)–(O) are in a GMR-hepCA (GMR-Gal4,UAS-hepCA) background.
(K) GMR-hepCA/+ (25uC). (L) GMR-hepCA/UAS-Mkk4 (25uC). Co-expression of Mkk4 also suppresses the small eye phenotype induced by HepCA. (M) GMR-
hepCA/UAS-Mkk4Asp (25uC). Co-expression of Mkk4Asp does not suppress the small eye phenotype induced by HepCA. (N) GMR-hepCA/+ (18uC). Weaker
expression of hepCA leads to a less severe small eye phenotype. (O) GMR-hepCA/+; Mkk4G587/Mkk4G673 (18uC). This phenotype is not suppressed, even
when both copies of Mkk4 are removed. (P) Aligment of the amino-acid sequence of Hep and Mkk4 catalytic region. The mutations introduced in
HepCA, Mkk4Asp and Mkk4Mut are indicated in red.
doi:10.1371/journal.pone.0007709.g001
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likely represent null alleles (Table 1, Figure 1A). Of note, all the 21
alleles behaved the same and lead to a strong suppression of the
Eiger-induced small eye phenotype.
Mkk4 mutant flies are viable and do not show obvious
morphological defects over Df(3R)Exel6149 or in heteroallelic
combinations. In some cases homozygous lethality is observed
which is most likely due to second mutations on the chromosome.
The absence of embryonic lethality associated with Mkk4 loss of
function demonstrates that unlike Hep/Mkk7, Mkk4 is not rate
limiting for dorsal closure of the Drosophila embryo.
Removing a single copy ofMkk4 leads to a potent suppression of
the Eiger-induced small eye phenotype (Figure 1B–E). Removing
two copies of Mkk4 does not significantly enhance this suppression
(Figure 1F). Therefore, in this context Mkk4 mutations are
dominant suggesting that Mkk4 is haplo-insufficient for Eiger-
induced small eye phenotype. Introducing a tubulin-Mkk4 rescue
transgene reverts the observed dominant suppression indicating
that indeed Mkk4 is responsible for this effect (Figure 1H). It is
important to note that hemizygous males for the hypomorphic hep1
allele also show a very good suppression of the Eiger-induced small
eye phenotype [11] (Figure 1G), indicating that in Drosophila both
MAPKKs, Mkk4 and Hep/Mkk7, are rate limiting for proper
transduction of the Eiger signal. This demonstrates that in
Drosophila, in contrast to mammals, Mkk4 is haplo-insufficient for
TNF superfamily ligand (Eiger)-mediated JNK activation.
Mkk4 Acts as MAPKK for dTAK1 Mediated Activation of
JNK
To confirm that Mkk4 indeed acts, like Hep, at the level of a
MAPKK in the JNK pathway, we performed epistasis experiments
in flies and cells as well as protein interaction studies. Removing one
(not shown) or both copies of Mkk4 does not suppress the small eye
phenotype induced by expression of an activated version of hep (hepCA)
in the Drosophila eye [12] (Figure 1N and O). This result suggests that
Mkk4 does not genetically function downstream of Hep. In S2 cells,
the expression of the MAPKKK dTAK1 potently activates the JNK
pathway, which leads to the activation of the AP1-luciferase-reporter
gene (Figure 2A). Co-RNAi against hep andMkk4 reduces this activity
(Figure 2A). However single RNAi treatment against either of the
two kinases was not sufficient to reduce the luciferase signal
(Figure 2A). In S2 cells the JNK pathway is also activated in a
dTAK1 dependent manner upon treatment by commercial
preparation of LPS (Figure 3A) [13,14,15]. RNAi against either hep
or Mkk4 reduces JNK activation upon commercial LPS treatment
(Figure 3A) suggesting that both kinases are rate limiting in this
situation. In agreement with this, the reduction in phosphorylated
JNK levels is enhanced when both kinases are targeted by RNAi at
the same time (Figure 3A). This last result confirms previous reports
indicating that both, Mkk4 and Hep, are required to mediate JNK
activation upon commercial LPS treatment [13,14]. Taking together
our RNAi experiments in S2 cells place Mkk4 downstream of the
MAPKKK dTAK1 in the control of JNK, confirming that Mkk4
functions as a classical MAPKK. Further evidence suggesting that
Mkk4 indeed acts as a MAPKK was obtained from protein
interaction studies. When expressed in S2 cells, N-terminally HA
tagged Mkk4 co-immunoprecipitated both, C-terminally FLAG
tagged dTAK1 and Bsk (Figure 2C). These results reveal that Mkk4
physically interacts with its upstream kinase dTAK1 as well as with its
downstream kinase Bsk.
In contrast to the intrinsic activity of HepCA (strong) and HepWT
(weak) (Figure 1K,N and 2B) [12], wild type Mkk4 does not
activate the JNK pathway when overexpressed in S2 cells
(Figure 2B) or in fly eyes (data not shown). Interestingly, wild
type Mkk4 has a dominant negative effect when co-expressed with
Eiger (Figure 1I) or HepCA (Figure 1L) in flies. This may stem from
its ability to interact with Bsk and dTAK1. Overexpressing Mkk4
may therefore titrate away Bsk and dTAK1. In an attempt to
generate a constitutive active Mkk4 (Mkk4Asp), we introduced the
Ser277RAsp and Thr281RAsp mutations, which corresponds to
the mutations that were introduced to generate HepCA [12]
(Figure 1P). Surprisingly, Mkk4Asp is not constitutively active,
neither in flies (not shown) nor in S2 cells (Figure 2B). However,
expressing Mkk4Asp suppresses GMR-egr (Figure 1J) but not GMR-
hepCA (Figure 1M). Finally a kinase dead version of Mkk4
(Mkk4Mut) where mutations Ser277RAla and Thr281RVal were
introduced (Figure 1P) behaved identically to Mkk4WT (not shown)
suggesting that the kinase activity of Mkk4 is not associated with its
dominant negative effect upon overexpression. This effect may
rather relate to differential binding ability towards dTAK1 and
Bsk of Mkk4WT and Mkk4Asp. Indeed in CoIP experiments
Mkk4Asp is still able to bind dTAK1 but no longer Bsk (Figure 2D).
Altogether our results therefore demonstrate that Mkk4 is a
MAPKK acting in parallel of Hep/Mkk7 and downstream of
dTAK1 in the activation of Bsk/JNK upon both Eiger expression
and Imd pathway activation by commercial LPS.
Mkk4 Is Dispensable for the Activation of the IKK/Relish
Cascade by dTAK1
dTAK1 is an importantMAPKKK regulating the activity of both
the JNK and IKK/Relish branch of the Imd cascade, a signaling
pathway regulating the expression of several immune effectors upon
infection [15,16]. In absence of a functional Imd/IKK/Relish
cascade as in dTAK1 mutants, flies are extremely sensitive to
systemic infection by Gram-negative bacteria, including Erwinia
Table 1. Mkk4 allelic series.
Mkk4 allele Lesion on DNA level (wt – mut) Lesion on protein level
G48 GCA – GTA Ala10Lys
G356 653bp insertion at Ser38 AA11 of insertion is a STOP
G673 CAG – TAG; TTC - TAC Gln66STOP; Phe184Tyr
G344 CGA - TGA Arg154STOP
G993 GAT - AAT Asp168Asn
G451 GTG - ATG Val171Met
G201 GAT - AAT Asp249Asn
G343 GTG - ATG Val250Met
G894 GTG - GAG Val250Asn
G136 CCG - TCG Pro252Ser
G863 GGT - GAT Gly269Asp
G414 CAG - TAG Gln273STOP
G39 CCG - CTG Pro292Leu
G583 CCG - TCG Pro292Ser
G657 GAT - AAT Asp308Asn
G504 GAG - AAG Glu318Lys
G270 CCC - CTC Pro325Leu
G587 TGG - TAG Trp329STOP
G1010 59 splice site intron 3: AG/GT - AG/AT -
G680 CAA – TAA Gln341STOP
G262 GTG - ATG Val361Met
Molecular lesions identified in Mkk4. Alleles are ordered according to their
position in the protein.
doi:10.1371/journal.pone.0007709.t001
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carotovora carotovora 15 (Ecc15) [16]. Therefore, we investigated if
Mkk4 is implicated in the control of the IKK/Relish branch of the
Imd pathway. To this end we tested if an Mkk4 deficiency leads to
similar immune phenotypes like dTAK1 loss of function. We
challenged Mkk4 mutants with Ecc15 and monitored their survival
over time. Figure 3B shows that in contrast to Relish and dTAK1
mutants, Mkk4 mutants survive like wild-type flies to this challenge.
This result therefore suggests that Mkk4 is dispensable for the
activation of the Imd/IKK/Relish cascade by dTAK1. Therefore,
the involvement of Mkk4 in the Imd cascade is restricted to the
dTAK1-mediated activation of the JNK branch (Figure 3A).
The Egr/dTAK1/Mkk4 Cascade Is Dispensable to Fight
Gram-Positive Cocci Infections
Recently, Schneider and colleagues showed that eiger mutants are
sensitive to systemic infection by gram-positive cocci, a type of
extracellular bacteria [17]. In order to test if this egr related process
relies on the same signaling cascade as the one activated in the eye
Figure 2. Mkk4 function as a MAPKK between dTAK1 and JNK/Bsk. (A) RNAi against Mkk4 and hep together significantly reduces dTAK1-
induced AP-1-luciferase reporter activity. (B) In contrast to Hep and HepCA, Mkk4 and Mkk4Asp do not induce AP-1-luciferase reporter activity on their
own. (C) Mkk4 physically interacts with dTAK1 and Bsk. (D) Mkk4Asp still interacts with dTAK1 but no longer binds to Bsk.
doi:10.1371/journal.pone.0007709.g002
Figure 3. Mkk4 activates the JNK branch of the Imd pathway, not the IKK/Relish branch. (A) RNAi against Mkk4 and/or hep reduces
phosphorylated JNK levels induced by commercial LPS in S2 cells. (B) Survival analysis of w1118 (closed diamond), Mkk4G673/Df(3R)Exel6149 (closed
square)), dTAK11 (cross) and RelishE20 (closed triangle) flies upon Erwinia carotovora carotovora 15 (Ecc15) septic injury.
doi:10.1371/journal.pone.0007709.g003
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upon egr expression, we challenged Mkk4 mutants with Staphyloccocus
aureus, a gram-positive coccus (Figure 4A). We compared their
viability to egr mutants and other mutants affecting the Toll signaling
pathway, spz and PGRP-SA, which contribute to the resistance to
systemic gram-positive cocci infection [18,19]. Figure 4A shows that
although egr3 mutant show a slight increased susceptibility to this
challenge compared to wild-type flies, however this was not as
pronounced as spz and PGRP-SA mutants. Importantly, Mkk4
mutants behave like wild-type animals in this setting. These results
corroborate our data showing that dTAK1 and dTAB2 null alleles are
not sensitive to Gram-positive cocci infection while being essential to
mediate the egr-induced small eye phenotype [10,16] (D. Ferrandon,
personal communication; P.G, K.B and F.L unpublished data).
Taken together these results therefore suggest that the canonical
dTAB2/dTAK1/Mkk4 signaling cassette is not required to mediate
the reported function of egr in fighting Gram-positive cocci infection.
In contrast to the strong susceptibility reported by Schneider et al,
our results revealed a mild susceptibility of egr3 alleles to Gram-
positive cocci infection. In order to confirm this phenotype, we
tested related or independent egr alleles (egr1 and egr66, respectively)
as well as the Regg1 parental line initially used to generate egr1 and
egr3 alleles [11,20]. In addition, we generated a precise excision of
the Regg1 P-element insertion, Regg11c, to create an isogenic wild-
type control line of the Regg1, egr1 and egr3 alleles. As expected, egr
transcripts were detected by RT-qPCR in all control lines (yw, Regg1
and Regg11c) but not in egr1, egr3 and egr66 mutant lines (Figure 4B).
Upon S.aureus infection egr1 and egr3 behave similarly and show a
mild susceptibility compared to wild-type flies and PGRP-SAseml
mutant flies. However, the egr66 mutants which lack the entire egr
coding region behave like wild-type controls (Figure 4C). When we
repeated this experiment using another, less pathogenic, gram-
positive coccus, Enteroccocus faecalis, we observed the same pattern of
results with egr1, egr3 and egr66 alleles, with egr66 beeing as susceptible
as wild-type flies to E.faecalis (Figure 4D). The reduced pathogenicity
of E.faecalis compared to S.aureus revealed that the Regg1 and Regg11c
fly lines show a mild susceptibility to this bacterial infection similarly
to egr1 and egr3 mutants. Taken together, these results therefore
suggest that the observed susceptibility of egr1 and egr3 mutants to
Gram-positive cocci is rather due to the genetic background of the
Regg1 line but not associated with egr loss of function.
Conclusion
In this study we have isolated for the first time an allelic series of
Drosophila Mkk4. Using these mutants we showed that Mkk4 is
dispensable for normal development and for host resistance to
systemic bacterial infection. Our genetic and biochemical
experiments demonstrate a non-redundant role for Mkk4 as a
MAPKK acting in parallel to Hep/Mkk7 in dTAK1-mediated
JNK activation in the Eiger and Imd pathways (Figure 5). In
contrast to mammals, it seems that in Drosophila both MAPKKs,
Hep/Mkk7 and Mkk4, are required to induce JNK upon TNF or
pro-inflammatory stimulation.
Methods
Fly Stocks
Fly stocks were maintained on polenta-agar medium at 23uC.
w1118 and yw fly strains were used as controls when appropriate.
Figure 4. The Egr/dTAK1/Mkk4 cascade is dispensable to fight gram-positive cocci infection. (A) Survival analysis of yw (closed diamond),
w1118 (closed square), Mkk4G673/Df(3R)Exel6149 (cross), eiger3 (egr; closed triangle), Spzrm7 (closed circle) and PGRP-SAseml (dash) flies upon
Staphylococcus aureus (S.aureus) septic injury. (B) Quantitative RT-qPCR analysis of basal egr expression in yw, Regg1, Regg11C, egr1, egr3 and egr66
adults. ND: Not Detected. RpL32 was used as the experimental expression standard. Relative DCtegr/DCtRpL32 ratios of yw males were anchored in 1 to
indicate fold-induction. Graphs represent the mean and S.D of relative ratios detected in 3 biological repetition of a pool of 15 males. (C–D) Survival
analysis of yw (closed diamond), eiger66 (closed square), eiger3 (cross), egr1 (closed triangle), Regg1 (closed circle), Regg11C (dash) and PGRP-SAseml
(open circle) flies upon (C) S.aureus or (D) Enterococcus faecalis (E.faecalis) septic injury.
doi:10.1371/journal.pone.0007709.g004
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Stocks carrying the UAS-Mkk4 (Mkk4) and tubulina1-Mkk4 transgene
were obtained by standard P-element-induced transformation.
dTAK11, RelishE20, spzrm7, PGRP-SAseml, Regg1, egr1, egr3, egr66 and
hep1 fly strains were described previously [4,11,20,21]. Regg11c was
generated by classical transposase-mediated precise excision of the
Regg1 P-element. Df(3R)Exel6149 was obtained from Bloomington
stock center,. UAS-hepCA, GMR-gal4 and UAS-egr were previously
described [10,12].
Genetic Mapping of the Alleles
From our dominant suppressor screen no lethal complementa-
tion group on the third chromosome could be identified (10).
Based on this observation we decided to combine two strategies in
order to map dominant suppressor mutations on the third
chromosome. First, we screened the whole Exelixis deficiency kit
[22] for dominant suppressors of the Egr-induced small eye
phenotype. Df(3R)Exel6149 was selected as a dominant suppressor
deficiency. This deficiency removes 26 genes including Mkk4 and
maps to the cytological location 85A [22]. Second, we performed a
classic genetic mapping by meiotic recombination. In absence of a
homozygous phenotype we made use of the dominant suppressor
phenotype in our sensitized background. To this end, three RFP-
(red fluorescent protein)-marked insertions at positions 62B, 85E
and 92A were used as genetic markers (one of them located close
to Df(3R)Exel6149 at position 85A, which was isolated as a
dominant suppressor from the deficiency screen). Chromosomes
carrying a suppressor mutation were allowed to recombine with
the RFP-marked chromosome in females. These virgins were
crossed back to GMR-egr/CyO males. The number of non-CyO
RFP(+) progeny (sorted under a fluorescent binocular) with a
suppressed eye phenotype in relation to the number of non-CyO
RFP(+) progeny with a small eye reflects the relative genetic
distance to the RFP insertion. In stocks carrying a suppressor
mutation that mapped very close to the RFP(+) insertion at 85E
(only 1-3% recombination frequency between suppressor mutation
and RFP(+) at 85E), and therefore also close to Df(3R)Exel6149 at
85A, the Mkk4 gene was checked for point mutations by
sequencing. The Mkk4 gene was chosen because it was the most
evident candidate from the 26 genes deleted in Df(3R)Exel6149.
Transgenes
The Mkk4 full-length cDNA (RE70055) was cloned into
pUAST [23] and into a vector containing the tubulina1 promoter
[24], respectively. For UAS-Mkk4Asp and UAS-Mkk4mut the corre-
sponding mutations were introduced by classical site directed
mutagenesis.
Figure 5. Proposed model for JNK regulation by Drosophila Mkk4 and Hemipterous/Mkk7 upon Eiger and Imd pathway activation.
(A) Following Eiger binding to Wengen a signaling complex consisting of dTRAF2-dTAB2-dTAK1 is stabilized, which allows dTAK1 activation.
Subsequently dTAK1 activates both Mkk4 and Hemipterous/Mkk7, which act non redundantly to activate Bsk/JNK. (B) Following Peptidoglycan
recognition PGRP-LC recruits the scaffold protein IMD, which activates by a yet unknown mechanism the dTAB2-dTAK1 complex. dTAK1
subsequently activates directly the IKK complex and both Mkk4 and Hemipterous/Mkk7 which act non redundantly to activate Bsk/JNK.
doi:10.1371/journal.pone.0007709.g005
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Sequencing
Genomic DNA was amplified by PCR using evenly spaced
primers in the Mkk4 coding region. PCR products were analyzed
by standard sequencing.
Drosophila Cell Culture and Transfection
Schneider (S2) cells were cultured in Schneider’s Drosophila
medium (Invitrogen, San Diego) supplemented with 10% fetal calf
serum and 1% penicillin/streptomysin at 25u. Cells were
transfected with expression vectors, using Cellfectin (Invitrogen)
according to the manufacturer’s protocol. Expression vectors:
pUAST-Mkk4, pUAST-HA-Mkk4, pUAST-Mkk4Asp, pUAST-HA-
Mkk4Asp, pUAST-dTAK1, pUAST-dTAK1-FLAG, pUAST-hep,
pUAST-hepCA, pUAST-bsk-FLAG, ptub-Gal4, pUAST-GFP.
Immunoprecipitation and Immunoblotting
S2 cells (0.756106 cells/well) were seeded into a 12-well plate.
One day after seeding cells were transfected with the indicated
expression vectors. Forty-eight hours after transfection the cells
were harvested and lysed in lysis buffer containing 150 mm NaCl,
50 mm Tris-HCl (pH 8.0), 1% Nonidet P-40, 0.5% deoxycholic
acid, and protease inhibitors (Complete Mini; Roche, Indianapo-
lis). Lysates were mixed with an anti-HA antibody and 25 ml of
Protein-A sepharose beads and allowed to rotate at 4uC overnight.
The beads were then collected and washed with the lysis buffer
four times. Proteins were eluted from the beads and resolved on a
4–12% NUPAGE gel system (Invitrogen) and transferred to a
nitrocellulose membrane. After blocking, the membrane was
incubated with anti-FLAG M2 antibody (Sigma) followed by
appropriate secondary antibodies conjugated with horseradish
peroxidase (HRP). Signals were detected with ECL reagents
(Amersham, Arlington Heights, IL).
LPS Treatment
S2 cells were treated with dsRNA (15 mg/106 cells) and split into
two halfs. One half was left untreated and the other half was
treated with lipopolysaccharide (LPS) (Sigma) at a concentration of
50 mg/ml for 10 min (note that commercial preparation of LPS
contains peptidoglycan, which potently induces the Imd signaling
cascade [21]). The cells were then lysed in lysis buffer. The lysates
were analyzed by immunoblotting to detect phosphorylated JNK
(anti-P-JNK, Promega, Madison, WI) and JNK (anti-JNK, Santa
Cruz Biotechnologies, Santa Cruz, CA).
Luciferase Assay
S2 cells (0.46106 cells/well) were seeded into a 24-well plate.
One day after seeding cells were transfected with an AP1-
luciferase reporter plasmid along with the indicated expression
vector. The total DNA concentration (1 mg) was kept constant by
supplementing with empty vector. Forty-eight hours after
transfection, cells were harvested, lysed in passive lysis buffer,
and luciferase activity was measured using the dual luciferase assay
system (Promega). The values shown reflect the relative luciferase
activity: the ratio of firefly (AP1 luciferase) and tub-renilla luciferase
activity of one representative experiment in which each transfec-
tion was made in duplicate.
Double-Stranded RNA Production
Double-stranded RNA (dsRNA) was prepared as described by
the Dixon lab [25]. Briefly, using PCR products as templates, the
MEGASCRIPT T7 transcription kit (Ambion, Austin, TX) was
used to produce RNA according to the manufacturer’s protocol.
RNA products were ethanol precipitated and resuspended in
DEPC-treated water. dsRNA was generated by annealing at 65u
for 30 min followed by slow cooling to room temperature. The
following sets of forward and reverse primers were used (T7
sequences are not indicated):
Mkk4: sense 59-caatcccccggatcagctaag-39; antisense 59-cacatccc-
gatggataatctttagc-39
hep: sense 59-gcaagtacattgtcaagtgcc-39; antisense 59-tggagcgttg-
gatcgccattgg-39
Bsk: sense 59-cgccgcaaaggaacttgg-39; antisense 59-tcagcatcatac-
cacacg-39
dTAK1: sense 59-gatgaccaacaatcgcgg-39; antisense 59-ggcgctg-
agtggcctcagc-39
GFP: sense 59-gaacttttcactggagttgtcc-39; antisense 59-gccatgtg-
taatcccagcagc-39
Quantitative Real-Time PCR
SYBR Green quantitative real-time PCR analysis was per-
formed as previously described [21]. Primer pairs for egr (sense: 59-
TAATCTCCAGCAGCGT-39, and antisense 59-GTAGTCTG-
CGCCAACA-39) and RpL32 (sense, 5-GAC GCT TCA AGG
GAC AGT ATC TG-3, and antisense, 59-AAA CGC GGT TCT
GCA TGA G-39) were used to detect target gene transcripts. The
amount of egr mRNA detected was normalized to control RpL32
mRNA values. Normalized data was used to quantify the relative
levels of a given mRNA according to cycling threshold analysis
(DCt). Relative DCtegr/DCtRpL32 ratios of WT controls were
anchored in 1 to indicate fold-induction. Graphs represent the
mean and S.D of relative ratios detected in 3 biological repetition
of a pool of 15 males.
Bacterial Strains and Infection Experiments
Systemic infections were performed by pricking 60 adult males
of 4 to 7 days old in the lateral thoracic region with a thin needle
previously dipped into a concentrated pellet of the following
bacteria. Erwinia carotovora carotovora 15 (Optical Density at 600 nm
(OD) 170, 29uC); Enterococcus faecalis (OD 10, 25uC) or Staphylococcus
aureus (OD 10, 25uC). Flies were incubated at the indicated
temperatures and their survival was monitored twice every day.
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